The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease

Autor: Willem Haverkamp, Cynthia de Luise, Mendel D. Haag, Guy van Camp, Miriam C. J. M. Sturkenboom, Katia M.C. Verhamme, R Zanettini, Gianluca Trifirò, Giampiero Mazzaglia, Douglas Ross, Jeanne P. Dieleman, Guy Brusselle, Ron M. C. Herings, M. Mostafa Mokhles, R Schade, Eva M. van Soest, Annamaria Colao

Publikováno v: Pharmacological Research, 65(3), 358-364. Academic Press
Mokhles, M M, Trifirò, G, Dieleman, J P, Haag, M D, Van Soest, E M, Verhamme, K M C, Mazzaglia, G, Herings, R, De Luise, C, Ross, D, Brusselle, G, Colao, A, Haverkamp, W, Schade, R, Van Camp, G, Zanettini, R & Sturkenboom, M C J M 2012, ' The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease ', Pharmacological Research, vol. 65, no. 3, pp. 358-364 . https://doi.org/10.1016/j.phrs.2011.11.009
Pharmacological Research, 65(3), 358-364. Academic Press Inc.

The aim of present study was to investigate the risk of heart failure associated with dopamine agonist use in patients with Parkinson's disease. The data sources of this study were four different population-based, healthcare databases in United Kingd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec63b4efb83ad4e0728a918224d1704
https://doi.org/10.1016/j.phrs.2011.11.009